Abstract
Strains of lactic acid and propionic acid bacteria and the A-5 bacterial association composed of the Lactobacillus brevis B-3/A-26, L. plantarum 2v/А-6, L. plantarum 14d/I, and Propionibacterium shermanii 2/10 cultures in equal proportion exhibiting high antitumor activity have been selected using the fungus Fusarium bulbigenum var. blasticola tumorlike growth model. L. acidophilus 27w, L. plantarum 2v/I, 2v/A-6, and 22A-310, L. fermentum 127A-4, L. cellobiosus 7n, L. salivarius 39n, P. shermanii 2/10, and the А-5 association were shown to inhibit completely the tumorlike growth of the fungus when present as 2% native cultures in the nutrient medium. The high antitumor activity of the A-5 association comparable with that of the therapeutic agents doxorubicin and cyclophosphamide was confirmed using human tumor cell lines originating from different organs (HepG2, RD, and H9). It has been demonstrated that the bacterial strains comprising the A-5 association were resistant to doxorubicin and methotrexate, the antitumor drugs tested.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adams, R., Methods of Cell Culture for Biochemists, Moscow: Mir, 1983.
Biffi, A., Coradini, D., Larsen, R., Riva, L., and Di Fronzo, G., Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line, Nutr. Cancer, 1997, vol. 28, pp. 93–99.
Brashears, M.M., Gilliland, S.E., and Buck, L.M., Bile–salt deconjugation and cholesterol removal from media by lactobacillus casei, J. Dairy Sci., 1998, vol. 36, pp. 281–301.
Doronin, A.F. and Shenderov, B.A., Funktsional’noe pitanie (Functional Nutrition), Moscow: Grant”, 2002.
Droganov, M., Cell Cultures. Theory and Technique, Plovdiv: VAP, 2004.
Farkas-Himsley, H. and Cheung, R., Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia, Cancer Res., 1976, vol. 36, no. 10, pp. 3561–3567.
Gavrilova, N.N., Berezin, V.E., Ratnikova, I.A., and Kadyrbaev, Zh., A mean for prevention of Newcastle disease, RF Preliminary Patent no. 17845, 2006, Byul. Izobret., 2006, no. 10.
Glushanova, N.A., Biological properties of lactobacilli, Byul. Sib. Med., 2003, no. 4, pp. 50–55.
Khabriev, R.U., Rukovodstvo po eksperimental’nomu doklinicheskomu izucheniyu novykh farmakologicheskikh veshchestv (Guidance for Experimental Preclinical Study of New Pharmaceuticals), Moscow: Meditsina, 2005.
Khaitov, R.M., Gushchin, I.S., Pinegin, B.V., and Zebrov, A.I., Doklinicheskie izucheniya effektivnosti khimioterapevticheskikh lekarstvennykh sredstv (Preclinical Study of the Efficacy of Chemotherapeutic Drugs), Moscow: MZ RF, 2005.
Lopatina, T.K., Blyakher, M.S., Nikolaenko, V.N., and Nilovskii, M.N., Immunomodulatory effects of eubiotic drugs, Vestn. Ross. Akad. Med. Nauk, 1997, no. 3, pp. 30–34.
Marteau, P. and Rambaud, J., Potential of using lactic acid bacteria for therapy and immunomodulation in man, FEMS Microbiol. Rev., 1993, vol. 12, pp. 207–220.
Masters, J.R., Animal Cell Culture: A Practical Approach, Oxford: Oxford Univ. Press, 2000.
Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Metods, 1983, vol. 65, pp. 55–63.
Nikitina, E.T. and Kalakutskii, L.V., The formation of secondary autonomous colonies of fungi on a synthetic medium during aging, Mikrobiologiya, 1977, vol. 46, no. 6, pp. 1087–1094.
Oda, M., Hasegawa, H., Komatsu, S., Kambe, M., and Tsuchiya, F., Antitumor polysaccharide from lactobacillus species, Agric. Biol. Chem., 1983, vol. 47, no. 7, pp. 1623–1625.
Onishchenko, G.G., Aleshkina, V.A., Afanas’eva, S.S., and Pospelova, V.V., Immunobiologicheskie preparaty i perspektivy ikh primeneniya v infektologii (Immunobiological Drugs and the Prospects of Their Use in Infectology), Moscow: VUNMTs Minzdrava RF, 2002.
Orrhage, K., Sillerstrom, E., Gustafsson, J.A., Nord, C.E., and Rafter, J., Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria, Mutat. Res., 1994, vol. 311, pp. 239–248.
Pidoux, M., Brillionet, J.M., and Qwemener, B., Characterization of the polysaccharides from Lactobacillus brevis and from Sugari kefir grans, Biotechnol. Lett., 1988, vol. 10, pp. 415–420.
Ramashkina, S. and Prabhavathi, B.F., Handbook of Drug Screening, New York: Marcel Dekker Inc., 2001.
Sawada, H., Furushiro, M., Hirai, K., Motoike, M., and Watanabe, T., Purification and characterization of an antihypertensive compound from lactobacillus casei, Agric. Biol. Chem., 1990, vol. 54, pp. 3211–3219.
Schiffrin, E.J., Rochat, F., Link-Amster, H., Aeschlimann, J.M., and Donnet-Hughes, A., Immunomodulation of human blood cells following the ingestion of lactic acid bacteria, J. Dairy Sci., 1995, vol. 78, pp. 491–497.
Tsoi, I.G., Saparov, A.S., and Timofeeva, I.K., Immunostimulatory effect of lactobacilli on the cytotoxicity of natural killer cells and the production of interferon, Mikrobiologiya, 1994, no. 6, pp. 112–113.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © I.A. Ratnikova, N.N. Gavrilova, K. Bayakyshova, Z.Zh. Turlybaeva, L.A. Kosheleva, N.M. Utegenova, 2018, published in Izvestiya Akademii Nauk, Seriya Biologicheskaya, 2018, No. 2, pp. 173–178.
Rights and permissions
About this article
Cite this article
Ratnikova, I.A., Gavrilova, N.N., Bayakyshova, K. et al. Antitumor Activity of Probiotic Bacteria and the Bacterial Association in the Tumor Growth Model and in Cell Culture. Biol Bull Russ Acad Sci 45, 155–159 (2018). https://doi.org/10.1134/S1062359018020103
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1062359018020103